| Pan-cancer analysis of whole genomes. S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ... Nature 578 (DKFZ-2020-01051), 82-93, 2020 | 2472* | 2020 |
| Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer A Fujimoto, M Furuta, Y Totoki, T Tsunoda, M Kato, Y Shiraishi, H Tanaka, ... Nature genetics 48 (5), 500-509, 2016 | 722 | 2016 |
| miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma M Furuta, K Kozaki, S Tanaka, S Arii, I Imoto, J Inazawa Carcinogenesis 31 (5), 766-776, 2010 | 710 | 2010 |
| Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations CP Wardell, M Fujita, T Yamada, M Simbolo, M Fassan, R Karlic, P Polak, ... Journal of hepatology 68 (5), 959-969, 2018 | 346 | 2018 |
| miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial CancerTumor-Suppressive miRNAs in Endometrial Cancer T Tsuruta, K Kozaki, A Uesugi, M Furuta, A Hirasawa, I Imoto, N Susumu, ... Cancer research 71 (20), 6450-6462, 2011 | 285 | 2011 |
| The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral CancermiR-218 Targeting Rictor A Uesugi, K Kozaki, T Tsuruta, M Furuta, K Morita, I Imoto, K Omura, ... Cancer research 71 (17), 5765-5778, 2011 | 284 | 2011 |
| Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity A Fujimoto, M Furuta, Y Shiraishi, K Gotoh, Y Kawakami, K Arihiro, ... Nature communications 6 (1), 1-8, 2015 | 231 | 2015 |
| The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma M Furuta, K Kozaki, K Tanimoto, S Tanaka, S Arii, T Shimamura, A Niida, ... PloS one 8 (3), e60155, 2013 | 166 | 2013 |
| Cancer whole-genome sequencing: present and future H Nakagawa, CP Wardell, M Furuta, H Taniguchi, A Fujimoto Oncogene 34 (49), 5943-5950, 2015 | 121 | 2015 |
| Circulating tumor DNA analysis for liver cancers and its usefulness as a liquid biopsy A Ono, A Fujimoto, Y Yamamoto, S Akamatsu, N Hiraga, M Imamura, ... Cellular and Molecular Gastroenterology and Hepatology 1 (5), 516-534, 2015 | 107 | 2015 |
| Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors M Furuta, M Ueno, A Fujimoto, S Hayami, S Yasukawa, F Kojima, ... Journal of hepatology 66 (2), 363-373, 2017 | 103 | 2017 |
| Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers Y Shiraishi, A Fujimoto, M Furuta, H Tanaka, K Chiba, KA Boroevich, ... PloS one 9 (12), e114263, 2014 | 86 | 2014 |
| Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer H Endo, T Muramatsu, M Furuta, N Uzawa, A Pimkhaokham, T Amagasa, ... Carcinogenesis 34 (3), 560-569, 2013 | 78 | 2013 |
| Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers M Furuta, H Tanaka, Y Shiraishi, T Unida, M Imamura, A Fujimoto, ... Oncotarget 9 (38), 25075, 2018 | 77 | 2018 |
| A practical method to detect SNVs and indels from whole genome and exome sequencing data D Shigemizu, A Fujimoto, S Akiyama, T Abe, K Nakano, KA Boroevich, ... Scientific reports 3 (1), 1-6, 2013 | 63 | 2013 |
| Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling M Fujita, N Matsubara, I Matsuda, K Maejima, A Oosawa, T Yamano, ... Oncotarget 9 (1), 969, 2018 | 51 | 2018 |
| Integrative Array-Based Approach Identifies MZB1 as a Frequently Methylated Putative Tumor Suppressor in Hepatocellular CarcinomaMZB1 Methylation in Hepatocellular Carcinoma S Matsumura, I Imoto, K Kozaki, T Matsui, T Muramatsu, M Furuta, ... Clinical cancer research 18 (13), 3541-3551, 2012 | 34 | 2012 |
| Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer H Taniguchi, A Fujimoto, H Kono, M Furuta, M Fujita, H Nakagawa Oncotarget 9 (40), 26144-26156, 2018 | 32 | 2018 |
| Correction: characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers M Furuta, H Tanaka, Y Shiraishi, T Uchida, M Imamura, A Fujimoto, ... Oncotarget 9 (60), 31789, 2018 | 3 | 2018 |
| Genome-wide profiling of somatic mutations in liver cancers revealed significantly mutated genes and non-coding regions in liver cancers M Furuta, A Fuimoto, Y Shiraishi, S Miyano, T Tsunoda, H Nakagawa Cancer Research 74 (19_Supplement), 5177-5177, 2014 | 1 | 2014 |
